Your browser doesn't support javascript.
loading
Anti-thrombotics and major adverse cardiovascular events in anti-phospholipid syndrome: a cross-sectional study using the 2016-2018 National Inpatient Sample database.
Grovu, R; Nguyen, A; Sangaraju, K; Wei, C; Mustafa, A; Slobodnick, A.
Afiliación
  • Grovu R; Internal Medicine Department, Staten Island University Hospital, New York, NY, USA.
  • Nguyen A; Harvard Medical School, USA.
  • Sangaraju K; Internal Medicine Department, Staten Island University Hospital, New York, NY, USA.
  • Wei C; Internal Medicine Department, Staten Island University Hospital, New York, NY, USA.
  • Mustafa A; Internal Medicine Department, Staten Island University Hospital, New York, NY, USA.
  • Slobodnick A; Rheumatology Department, Staten Island University Hospital, New York, NY, USA.
Scand J Rheumatol ; 52(6): 696-702, 2023 11.
Article en En | MEDLINE | ID: mdl-37584636
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Síndrome Antifosfolípido Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Scand J Rheumatol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Síndrome Antifosfolípido Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Scand J Rheumatol Año: 2023 Tipo del documento: Article